Literature DB >> 186548

Phospholipid removal during degradation of rat plasma very low density lipoprotein in vitro.

S Eisenberg, D Schurr.   

Abstract

The hydrolysis of glycerophospholipids in very low density lipoprotein by enzyme(s) released into circulation after the injection of heparin to rats was studied. [32P]Lysolecithin was formed rapidly from [32P]lecithin when very low density lipoprotein, labeled biosynthetically with 32P, was incubated with postheparin plasma. The [32P]lysolecithin was associated with the plasma protein fraction of density greater than 1.21 g/ml, whereas [32P]lecithin exchanged between very low and high density lipoproteins. Inhibition of the plasma lecithin: cholesterol acyl transferase activity did not change the excess [32P]lysolecithin formation in postheparin plasma, and only a negligible amount of radioactivity was associated with blood cells when the incubation was repeated in whole blood. Analysis of the results has demonstrated that phospholipids are removed from VLDL by two pathways: hydrolysis of glycerophospholipids by the heparin-releasable phospholipase activity (greater than50%) and transfer to high density lipoproteins (less than50%). The tissue origin of the postheparin phospholipase was studied in plasma obtained from intact rats and supradiaphragmatic rats using specific inhibitors of the extrahepatic lipase system (protamine sulfate and 0.5 M NaCl). The phospholipase activity could be ascribed to both the hepatic and extrahepatic lipase systems. It is concluded that hydrolysis of glycerophospholipids is the major mechanism responsible for the removal of phospholipids from very low density lipoprotein during the degradation of the lipoprotein. It is suggested that phospholipid hydrolysis occurs concomitantly with triglyceride hydrolysis, predominantly in extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186548

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

3.  Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart.

Authors:  T Chajek; S Eisenberg
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

4.  [Effect of diurnal distribution of food intake on 24-h profiles of plasma lipoproteins (author's transl)].

Authors:  J Schneider; H Tauber
Journal:  Klin Wochenschr       Date:  1981-02-16

5.  Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat.

Authors:  T G Redgrave; D M Small
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II.

Authors:  J Stocks; D J Galton
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

7.  Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart.

Authors:  C J Fielding
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis.

Authors:  E E Windler; S Preyer; H Greten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system.

Authors:  S Eisenberg
Journal:  Klin Wochenschr       Date:  1983-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.